← Back to Search

Amino Acid Supplement

Treatment Group for Nutritional Stunting

N/A
Waitlist Available
Led By Emir Tas, MD
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Summary

This trial is testing whether a nutritional supplement with essential amino acids can help short children who haven't reached puberty grow taller. These children often have lower weight compared to their peers and don't respond well to growth hormone treatments. The supplement provides important nutrients that might help their bodies grow better.

Eligible Conditions
  • Nutritional Stunting
  • Growth Delay

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Linear Growth
Secondary study objectives
Body Composition
Other study objectives
Serum amino acid concentrations
Serum growth factor concentrations

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Treatment GroupActive Control1 Intervention
* This is a double-blind study. Participants and the investigators will be blinded to the intervention. * Children in the treatment (intervention) arm will receive essential amino acids (EAA) twice a day. * Children 3 to 5 years of age will be asked to take either 8.5 g (1 serving) of EAA supplement or placebo at breakfast and at bedtime. * Children 6 to 11 years of age will be assigned to take either 17 g (2 servings) of EAA supplement or placebo at breakfast and at bedtime. * EAA and placebo dissolve easily in any liquid beverage and can be taken on empty versus full stomach.
Group II: PlaceboPlacebo Group1 Intervention
* This is a double-blind study. Participants and the investigators will be blinded to the intervention. * Children in the placebo arm will receive placebo twice a day. EAA and placebo supplements will look and taste alike. The same flavoring ingredients (stevia blend, citric acid, malic acid, natural flavors, tartaric acid, fruit and vegetable juice for color) will be used in both products at the same amount. * Children 3 to 5 years of age will be asked to take either 8.5 g (1 serving) of EAA supplement or placebo at breakfast and at bedtime. * Children 6 to 11 years of age will be assigned to take either 17 g (2 servings) of EAA supplement or placebo at breakfast and at bedtime. * EAA and placebo dissolve easily in any liquid beverage and can be taken on empty versus full stomach.

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
493 Previous Clinical Trials
150,939 Total Patients Enrolled
Arkansas Children's Hospital Research InstituteLead Sponsor
136 Previous Clinical Trials
5,023,548 Total Patients Enrolled
Emir Tas, MDPrincipal InvestigatorArkansas Children's Research Insitute
1 Previous Clinical Trials
40 Total Patients Enrolled
~5 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top